Eosinophil-Derived Neurotoxin Is Elevated in Patients with Amyotrophic Lateral Sclerosis

Figure 1

Serum EDN is elevated in patients with ALS. Serum concentrations of EDN (a) and ECP (b) in controls (𝑁=44) and patients with AD (𝑁=39), PD (𝑁=40), and ALS (𝑁=44). ^∗𝑃<0.05, ^∗∗𝑃<0.01, ^∗∗∗𝑃<0.005. The bold black line indicates the mean.

(a)

(b)